News

18 January 2022

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story

18 January 2022

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story

6 January 2022

TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation

Read full story

6 January 2022

i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules

Read full story

5 January 2022

SRI International announces collaboration agreement with Janssen

Read full story

4 January 2022

Genocea Biosciences Provides Corporate Update

Read full story